New Venous Thromboembolism Findings from University of California Davis Outlined [Evaluation of Standard Versus Reduced Dose Apixaban for the Treatment of Venous Thromboembolism In Patients With Severe Renal Disease (Esrd-vte)]

Press/Media

Period11 Jul 2023

Media coverage

1

Media coverage

  • TitleNew Venous Thromboembolism Findings from University of California Davis Outlined [Evaluation of Standard Versus Reduced Dose Apixaban for the Treatment of Venous Thromboembolism In Patients With Severe Renal Disease (Esrd-vte)]
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date11/07/23
    URLct.moreover.com/?a=51280535143&p=1gw&v=1&x=p7osfLvr6Ie_GFHFjeXAKw
    PersonsCraig W. Stevens